Skip to content

Pegasus Biwave System

by Pegasus Airwave, Inc.

510(k) K933004

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK933004 Date7 Mar 1994ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
FNM
Device Class
Class II
Regulation
21 CFR Part 880.5550
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Pegasus Biwave System is an alternating pressure air flotation mattress designed to support and relieve pressure on patients at risk of developing pressure ulcers. Classified as a Class II medical device, it uses sequential inflation and deflation cycles to distribute body weight and improve circulation in dependent areas.

This system is intended for use in general hospital settings and is supplied as a reusable device. It requires no sterilisation between uses and is compatible with standard hospital environments. Multiple sizes and configurations are available, as indicated by the associated FEI numbers. The device holds an FDA 510(k) clearance under product code FNM and regulation number 880.5550, with a decision date of March 7, 1994.

Other devices from Pegasus Airwave, Inc.

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of patients is the Pegasus Biwave System designed to support, and where is it typically used?

    The Pegasus Biwave System is designed to support patients at risk of developing pressure ulcers by distributing body weight and improving circulation in dependent areas through sequential air inflation and deflation. It is specifically intended for use in general hospital settings, making it suitable for patients who require pressure relief during prolonged bed rest or immobility.

  • Is the Pegasus Biwave System reusable, and if so, what cleaning or maintenance is required between uses?

    Yes, the Pegasus Biwave System is a reusable device. Since it requires no sterilization between uses, standard hospital cleaning protocols—such as wiping with disinfectants compatible with air flotation mattresses—should be followed to maintain hygiene and functionality. No additional maintenance is specified beyond routine cleaning.

  • How do I determine the correct size or configuration for a patient, and are multiple sizes available?

    Multiple sizes and configurations of the Pegasus Biwave System are available, as indicated by the associated FEI numbers in the regulatory records. To determine the correct size, measure the patient’s dimensions (e.g., length, width) and match them to the manufacturer’s sizing guidelines. The system is designed to accommodate various patient needs, ensuring proper support and pressure redistribution.

  • Does the Pegasus Biwave System require any special storage conditions, and how should it be stored when not in use?

    The Pegasus Biwave System is designed for standard hospital environments, so no specialized storage conditions are specified. When not in use, it should be stored in a clean, dry area away from direct sunlight or extreme temperatures. Ensure the mattress is fully deflated and stored flat to prevent damage or deformation.

  • What regulatory pathway was followed for FDA clearance of the Pegasus Biwave System, and what does this mean for its use?

    The Pegasus Biwave System holds an FDA 510(k) clearance under product code FNM and regulation number 880.5550, with a decision date of March 7, 1994. This clearance indicates the device was determined to be *substantially equivalent* to a legally marketed predicate device, meaning it meets FDA standards for safety and effectiveness as a Class II medical device. Clinicians and buyers can rely on this clearance to confirm its compliance with U.S. regulatory requirements for use in general hospital settings.